
|Articles|September 21, 2006
PhRMA Names New Chairman
Author(s)Pharmaceutical Technology Editors
Kevin Sharer has become chairman of the board of the Pharmaceutical Research and Manufacturers of America upon the resignation of Peter R. Dolan.
Advertisement
Washington, DC (Sept. 15)-Kevin Sharer has become chairman of the board of the Pharmaceutical Research and Manufacturers of America (PhRMA,
Sharer emphasized PhRMA's commitment to “drive American innovation, confront the toughest healthcare problems, deliver great value to patients, and make medicines available to patients who need them.” He added that PhRMA will “continue partnering with patients, physicians, and other healthcare stakeholders to achieve these goals.”
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Chooses 7 Companies for PreCheck Pilot
2
Documentation Reliability Across Contractors: A Quality Systems Approach
3
Lonza Increases HPAPI Production at Visp Facility
4
Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers
5




